Correlation Between Canntab Therapeutics and RAMM Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and RAMM Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and RAMM Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and RAMM Pharma Corp, you can compare the effects of market volatilities on Canntab Therapeutics and RAMM Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of RAMM Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and RAMM Pharma.

Diversification Opportunities for Canntab Therapeutics and RAMM Pharma

1.0
  Correlation Coefficient

No risk reduction

The 3 months correlation between Canntab and RAMM is 1.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and RAMM Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAMM Pharma Corp and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with RAMM Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAMM Pharma Corp has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and RAMM Pharma go up and down completely randomly.

Pair Corralation between Canntab Therapeutics and RAMM Pharma

If you would invest  1.30  in Canntab Therapeutics Limited on September 14, 2024 and sell it today you would lose (1.29) from holding Canntab Therapeutics Limited or give up 99.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy27.13%
ValuesDaily Returns

Canntab Therapeutics Limited  vs.  RAMM Pharma Corp

 Performance 
       Timeline  
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Canntab Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
RAMM Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RAMM Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, RAMM Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Canntab Therapeutics and RAMM Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Canntab Therapeutics and RAMM Pharma

The main advantage of trading using opposite Canntab Therapeutics and RAMM Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, RAMM Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAMM Pharma will offset losses from the drop in RAMM Pharma's long position.
The idea behind Canntab Therapeutics Limited and RAMM Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format